CSIMarket
 

Angiodynamics Inc   (ANGO)
Other Ticker:  
 

Angiodynamics Inc 's

Competitiveness


 

ANGO Sales vs. its Competitors Q4 2023







Revenue Growth Comparisons




Net Income Comparison




<<  ANGO Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Angiodynamics Inc Contracts

AngioDynamics Expands Horizons: Completes $45 Million Sale to Spectrum Vascular, Achieves Milestone in Groundbreaking APEX-AV Study

AngioDynamics Announces $45 Million Sale of PICC and Midline Product Portfolios to Spectrum Vascular, Completes Patient Enrollment in APEX-AV StudyIn a significant strategic move, AngioDynamics, Inc. (NASDAQ: ANGO), an influential medical technology company specializing in enhancing blood flow, cancer treatment advancements, and improving the overall quality of patients' lives, has successfully concluded the sale of its PICC and Midline product portfolios to Spectrum Vascular for a substantial sum of up to $45 million. Spectrum Vascular, a forward-thinking medical device enterprise focused on vascular access and medication management, is set to further enhance its position in the market with this acquisition...





Who are Angiodynamics Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com